4//SEC Filing
Luly Jay R. 4
Accession 0001062993-23-021379
CIK 0001177648other
Filed
Nov 21, 7:00 PM ET
Accepted
Nov 22, 5:10 PM ET
Size
5.4 KB
Accession
0001062993-23-021379
Insider Transaction Report
Form 4
Luly Jay R.
DirectorPresident and CEO
Transactions
- Award
Stock Option (right to buy)
2023-11-22+264,000→ 264,000 totalExercise: $8.99Exp: 2033-11-22→ Common Stock (264,000 underlying)
Footnotes (1)
- [F1]Such option will become exercisable (subject to the optionholder's continued employment) quarterly in substantially equal installments (any fractional shares to be cumulated and to become exercisable at the end of the earliest succeeding quarterly period in which a whole share equivalent is accumulated) over four years from the date of grant (November 22, 2023).
Issuer
ENANTA PHARMACEUTICALS INC
CIK 0001177648
Entity typeother
Related Parties
1- filerCIK 0001571211
Filing Metadata
- Form type
- 4
- Filed
- Nov 21, 7:00 PM ET
- Accepted
- Nov 22, 5:10 PM ET
- Size
- 5.4 KB